Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis.
about
Metabolic syndrome and hepatocellular carcinoma: two growing epidemics with a potential linkGenetic, metabolic and environmental factors involved in the development of liver cirrhosis in MexicoGenetic background in nonalcoholic fatty liver disease: A comprehensive reviewPrevention of hepatocellular carcinoma: Focusing on antioxidant therapyDysregulation of iron and copper homeostasis in nonalcoholic fatty liverIron and non-alcoholic fatty liver diseaseTransitions of histopathologic criteria for diagnosis of nonalcoholic fatty liver disease during the last three decadesEffect of C282Y genotype on self-reported musculoskeletal complications in hereditary hemochromatosisAssociation between the HFE C282Y, H63D Polymorphisms and the Risks of Non-Alcoholic Fatty Liver Disease, Liver Cirrhosis and Hepatocellular Carcinoma: An Updated Systematic Review and Meta-Analysis of 5,758 Cases and 14,741 ControlsLiver cirrhosis induced by long-term administration of a daily low dose of amiodarone: a case reportThe global epidemiology of hepatocellular carcinoma: present and futureAdvanced MRI methods for assessment of chronic liver diseaseEffect of multipeak spectral modeling of fat for liver iron and fat quantification: correlation of biopsy with MR imaging resultsAccelerated T2*-compensated fat fraction quantification using a joint parallel imaging and compressed sensing frameworkDoes fat suppression via chemically selective saturation affect R2*-MRI for transfusional iron overload assessment? A clinical evaluation at 1.5T and 3T.Role of iron in hepatic fibrosis: one piece in the puzzleMultiecho water-fat separation and simultaneous R2* estimation with multifrequency fat spectrum modelingNonalcoholic fatty liver disease: diagnostic and fat-grading accuracy of low-flip-angle multiecho gradient-recalled-echo MR imaging at 1.5 T.Quantification of hepatic steatosis with MRI: the effects of accurate fat spectral modelingQuantification of hepatic steatosis with 3-T MR imaging: validation in ob/ob mice.Independent estimation of T*2 for water and fat for improved accuracy of fat quantificationInterrelationships of alcohol and iron in liver disease with particular reference to the iron-binding proteins, ferritin and transferrin.Hereditary haemochromatosis: diagnosis and management in the gene era.Study of the correlation between serum ferritin levels and the aggregation of metabolic disorders in non-diabetic elderly patients.The haemochromatosis gene: a co-factor for chronic liver diseases?Evolving concepts in the pathogenesis of NASH: beyond steatosis and inflammation.The haemochromatosis gene: a global perspective and implications for the Asia-Pacific region.Association of the rs738409 polymorphism in PNPLA3 with liver damage and the development of nonalcoholic fatty liver disease.Effect of hepatic iron concentration reduction on hepatic fibrosis and damage in rats with cholestatic liver diseaseInhibitory effect of angiotensin II receptor antagonist on hepatic stellate cell activation in non-alcoholic steatohepatitisQuantification of hepatic steatosis with T1-independent, T2-corrected MR imaging with spectral modeling of fat: blinded comparison with MR spectroscopyInfluence of iron on the severity of hepatic fibrosis in patients with chronic hepatitis C.Nonalcoholic fatty liver disease and HFE gene mutations: a Polish study.Estimation of liver T₂ in transfusion-related iron overload in patients with weighted least squares T₂ IDEAL.Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy.Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association.Nonalcoholic steatohepatitis in Asian Indians is neither associated with iron overload nor with HFE gene mutations.Quantitative analysis of hepatic fat fraction by single-breath-holding MR spectroscopy with T₂ correction: phantom and clinical study with histologic assessment.Non-alcoholic steatohepatitis (NASH): where are we now and where are we going?Genetic determinants of hepatic steatosis in man.
P2860
Q24631619-BA64B125-A6AC-412B-A9C1-37CBA4B74FD9Q26778035-03268B6E-4C16-46D1-AFC0-D2AB8D439C0DQ26780248-7800DC41-CF54-4FBC-86B5-358CE57B8104Q26853520-1023F3ED-29F4-4446-A592-73B798DF2D94Q26996539-0B308CDC-C5EF-4728-8D50-CDF3D52E1C1AQ28070303-35425F95-2071-42E6-9724-92BA8BD29902Q28088798-9DDB947F-5F98-4B9C-A2BE-8C8C7B6D9EFBQ28545156-C17B841C-C5C3-4067-8096-F72D0BEA5711Q28554312-F019FA80-9E06-41F9-8EC5-01B751042614Q28608404-EDF8597F-3171-436E-87A4-1907700C3605Q28654353-C2A0730C-61FC-49FF-9D8E-CBDDC81A62E3Q30478601-CBF67414-DCF1-43E6-9B5C-D8B674E94F8CQ30559328-7BEDEE63-AFA0-4AFF-8F87-46EE5F73AF45Q30587289-D211E9CE-9C47-4FC3-BE83-708CFF957B4BQ30989859-E6650F21-FF10-4FF0-99AC-51ACAFCEE598Q33344424-8372C00B-2928-4044-AA57-403D88149118Q33379855-179307B0-4198-495E-BC28-725E9F2DC250Q33409801-15349B9B-EFB7-45C9-9070-CE0B8FCFA101Q33453637-CC43A881-4E1C-4F4C-9D87-657BD65CB924Q33520636-84AC813F-6289-4938-8389-B6BB11671A1EQ33550434-B79714D9-8288-4144-AC0D-BD8285C6078FQ33590854-E71C676B-6B58-4CD1-9946-2BFB293867CFQ33603907-76C56BF2-C769-422D-95DD-32FFF1716613Q33706281-E03F858C-4367-4531-BF76-1A7037FD1A18Q33731087-748B33E8-056E-4D36-8C82-1AE818D706BAQ33755829-A8B95BDD-F5F5-4261-8C0B-12606A4087BEQ33760038-B91E9389-BD62-4A87-BB17-5F7F15E21500Q33777486-76E89369-DFDD-4977-85BC-29E9138A97A6Q33788123-7BA72527-D1E3-4C77-8B85-469F411C4A6CQ33788174-7012617E-3465-4BD8-890F-30876FC6E987Q33797528-DB7C3082-2F98-4E39-B9A8-556FFBCAD161Q33867064-1E0DA38D-493B-43F8-8E6A-0173377B7C23Q33879464-6F31A9B5-563D-41C8-A708-9BE27343004AQ33901119-9CA3BC6E-D70A-4753-8BA9-C6C410969F13Q34021973-B2B994BC-4286-42C2-ACD1-983837711363Q34112671-3DF962B5-960B-4046-89D2-94D491E546E4Q34382307-1232FF9D-754F-4498-A62B-558C37E03BB3Q34504586-5A51636B-46A0-4834-83A0-ABFE0890BD6DQ34598353-F48E48A0-AA08-48A9-8995-B108DFE0696DQ34646183-81A17D8A-A2BF-46D5-BC2E-E0728F638A63
P2860
Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Increased hepatic iron concent ...... iated with increased fibrosis.
@en
Increased hepatic iron concent ...... iated with increased fibrosis.
@nl
type
label
Increased hepatic iron concent ...... iated with increased fibrosis.
@en
Increased hepatic iron concent ...... iated with increased fibrosis.
@nl
prefLabel
Increased hepatic iron concent ...... iated with increased fibrosis.
@en
Increased hepatic iron concent ...... iated with increased fibrosis.
@nl
P2093
P1433
P1476
Increased hepatic iron concent ...... iated with increased fibrosis.
@en
P2093
Jazwinska EC
MacDonald GA
P304
P356
10.1016/S0016-5085(98)70482-2
P407
P577
1998-02-01T00:00:00Z